Kalbe Farma Tbk PT
OTC:PTKFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kalbe Farma Tbk PT
OTC:PTKFF
|
ID |
|
Kiyo Bank Ltd
TSE:8370
|
JP |
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
ID |
|
C
|
Cairo Communication SpA
SWB:CI1A
|
IT |
|
Karat Packaging Inc
F:0WJ
|
US |
|
F
|
Fauji Cement Company Ltd
KAR:FCCL
|
PK |
|
C
|
Cnergyico Pk Ltd
KAR:CNERGY
|
PK |
|
L
|
Lima Dua Lima Tiga PT Tbk
IDX:LUCY
|
ID |
|
L
|
LCK Global Kedaton Tbk PT
IDX:LCKM
|
ID |
|
D
|
Dr Martens PLC
OTC:DRMTY
|
UK |
|
N
|
NatureWise Biotech & Medicals Corp
TPEX:4732
|
TW |
|
Lippo Karawaci Tbk PT
IDX:LPKR
|
ID |
|
Trisula International Tbk PT
IDX:TRIS
|
ID |
|
A
|
Amundi SA
SWB:ANI
|
FR |
|
N
|
Nazir Cotton Mills Ltd
KAR:NCML
|
PK |
|
B
|
Bpost SA
XMUN:13B
|
BE |
|
S
|
Soracom Inc
TSE:147A
|
JP |
|
A
|
Askari Bank Ltd
KAR:AKBL
|
PK |
|
R
|
RDC Semiconductor Co Ltd
TPEX:3228
|
TW |
|
Moonpig Group PLC
F:769
|
UK |
|
I
|
Indosat Tbk PT
F:IDO1
|
ID |
Bankruptcy Probability
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kalbe Farma Tbk PT Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ID |
|
Kalbe Farma Tbk PT
IDX:KLBF
|
34.2T IDR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
613.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
350.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
341B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
222.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
339.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kalbe Farma Tbk PT's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kalbe Farma Tbk PT has total debt of 804.1B IDR. This includes both short-term (628.1B IDR) and long-term (176B IDR) debt.
You can find a full breakdown on its Balance Sheet.